According to the Arkansas myeloma cohort (GEO accession number GSE4581) [31], the elevated expression of two m6A demethylases (ALKBH5 and FTO) was correlated with poor patient survival (Figs. 1G and S1E). The gene discussed is ALKBH5; the disease is plasma cell myeloma.